Cardiac Resynchronization Therapy Market: Size, Trends, and Strategic Insights The cardiac resynchronization therapy market is witnessing significant expansion driven by rising incidences of heart failure and advancements in cardiac devices. This industry’s growth underscores increasing adoption of innovative CRT solutions to improve patient outcomes and reduce heart disease burden globally. Market Size and Overview The cardiac resynchronization therapy (CRT) market is estimated to be valued at USD 7.94 billion in 2025 and is expected to reach USD 12.42 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. https://www.coherentmi.com/industry-reports/cardiac-resynchronization-therapy-market